Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 546

1.

High prevalence of childhood multi-drug resistant tuberculosis in Johannesburg, South Africa: a cross sectional study.

Fairlie L, Beylis NC, Reubenson G, Moore DP, Madhi SA.

BMC Infect Dis. 2011 Jan 26;11:28. doi: 10.1186/1471-2334-11-28.

2.

The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.

Seddon JA, Hesseling AC, Marais BJ, Jordaan A, Victor T, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Jul;16(7):928-33. doi: 10.5588/ijtld.11.0679. Epub 2012 May 8.

PMID:
22583610
3.

Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa.

Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, Simpson J, Barnard M, Coetzee G, van Cutsem G, Goemaere E.

PLoS One. 2010 Nov 15;5(11):e13901. doi: 10.1371/journal.pone.0013901.

4.

Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay.

Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, Heysell S, Li X, Moll A, Friedland G, Sturm AW, Gandhi NR.

Am J Respir Crit Care Med. 2011 May 15;183(10):1427-33. doi: 10.1164/rccm.201009-1449OC. Epub 2011 Feb 4.

PMID:
21297071
5.

Rifampicin mono-resistance in Mycobacterium tuberculosis in KwaZulu-Natal, South Africa: a significant phenomenon in a high prevalence TB-HIV region.

Coovadia YM, Mahomed S, Pillay M, Werner L, Mlisana K.

PLoS One. 2013 Nov 6;8(11):e77712. doi: 10.1371/journal.pone.0077712. eCollection 2013.

6.

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.

Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE.

PLoS One. 2012;7(11):e49898. doi: 10.1371/journal.pone.0049898. Epub 2012 Nov 30. Erratum in: PLoS One. 2013;8(6). doi: 10.1371/annotation/47420ec0-db00-4994-a0de-86b5e5d713f4.

7.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
8.

Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia.

Yimer SA, Agonafir M, Derese Y, Sani Y, Bjune GA, Holm-Hansen C.

APMIS. 2012 Jun;120(6):503-9. doi: 10.1111/j.1600-0463.2011.02861.x. Epub 2012 Jan 12.

PMID:
22583363
9.

Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.

Fairlie L, Muchiri E, Beylis CN, Meyers T, Moultrie H.

Int J Tuberc Lung Dis. 2014 Jun;18(6):676-81. doi: 10.5588/ijtld.13.0839.

PMID:
24903938
10.

Multi-drug resistant tuberculosis burden and risk factors: an update.

Marahatta SB.

Kathmandu Univ Med J (KUMJ). 2010 Jan-Mar;8(29):116-25. Review.

PMID:
21209520
11.

Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa.

Schnippel K, Rosen S, Shearer K, Martinson N, Long L, Sanne I, Variava E.

Trop Med Int Health. 2013 Jan;18(1):109-16. doi: 10.1111/tmi.12018. Epub 2012 Nov 21.

12.

Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.

Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR.

PLoS One. 2010 Dec 29;5(12):e15735. doi: 10.1371/journal.pone.0015735.

13.

Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.

Mishra B, Rockey SM, Gupta S, Srinivasa H, Muralidharan S.

Trop Doct. 2012 Jan;42(1):35-7. doi: 10.1258/td.2011.110247. Epub 2011 Nov 11.

PMID:
22080484
14.

Multidrug- and isoniazid-resistant tuberculosis in three high HIV burden African regions.

Sanchez-Padilla E, Ardizzoni E, Sauvageot D, Ahoua L, Martin A, Varaine F, Adatu-Engwau F, Akeche G, Salaniponi F, Bonnet M.

Int J Tuberc Lung Dis. 2013 Aug;17(8):1036-42. doi: 10.5588/ijtld.12.0842.

PMID:
23827027
15.

Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome.

Seddon JA, Hesseling AC, Willemse M, Donald PR, Schaaf HS.

Clin Infect Dis. 2012 Jan 15;54(2):157-66. doi: 10.1093/cid/cir772. Epub 2011 Nov 3.

PMID:
22052896
16.

Multidrug-resistant tuberculous meningitis in children in Durban, South Africa.

Padayatchi N, Bamber S, Dawood H, Bobat R.

Pediatr Infect Dis J. 2006 Feb;25(2):147-50.

PMID:
16462292
17.

Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.

Vella V, Racalbuto V, Guerra R, Marra C, Moll A, Mhlanga Z, Maluleke M, Mhlope H, Margot B, Friedland G, Shah NS, Gandhi NR.

Int J Tuberc Lung Dis. 2011 Sep;15(9):1170-5, i. doi: 10.5588/ijtld.10.0781.

PMID:
21943840
18.

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.

Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.

Int J Tuberc Lung Dis. 2012 Dec;16(12):1588-93. doi: 10.5588/ijtld.12.0322. Epub 2012 Oct 2.

PMID:
23032215
19.
20.

[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].

Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I.

Pneumonol Alergol Pol. 2002;70(3-4):193-202. Polish.

PMID:
12271966

Supplemental Content

Support Center